Pneumococcal-associated purpura fulminans in a healthy infant.
Noguera
Antoni
A
Department of Pediatrics, Unitat Integrada Hospital Sant Joan de Déu-Hospital Clínic, Universitat de Barcelona, Barcelona, Spain. tonnoguera@hotmail.com
Fortuny
Clàudia
C
Pons
Marti
M
Cambra
Francisco
F
Palomeque
Antonio
A
D002439:Cefotaxime / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003646:Debridement; D024901:Drug Resistance, Multiple, Bacterial; D004359:Drug Therapy, Combination; D005334:Fever / Q000209:etiology; D005528:Foot / Q000098:blood supply; D005734:Gangrene; D006225:Hand / Q000098:blood supply; D006801:Humans; D011695:IgA Vasculitis / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery; D007121:Immunocompetence; D007223:Infant; D007511:Ischemia / Q000209:etiology; D008297:Male; D026741:Physical Therapy Modalities; D010949:Plasma; D011008:Pneumococcal Infections / Q000150:complications* / Q000188:drug therapy; D011018:Pneumonia, Pneumococcal / Q000150:complications / Q000188:drug therapy; D019651:Plastic Surgery Procedures; D018805:Sepsis / Q000150:complications* / Q000188:drug therapy; D016038:Skin Transplantation; D014640:Vancomycin / Q000627:therapeutic use
D014640:Vancomycin; D002439:Cefotaxime